AS
FULC icon

Altshuler Shaham’s Fulcrum Therapeutics FULC Stock Holding History

Altshuler Shaham’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366 Hold
100
– – ﹤0.01% 464
2026
Q1 		$767 Hold
100
– – ﹤0.01% 416
2025
Q4 		$1.13K Buy
+100
New +$1.02K ﹤0.01% 386

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Altshuler Shaham's FULC Position: Q2 2026 in Review

Altshuler Shaham held its Fulcrum Therapeutics (FULC) position steady in Q2 2026 at 100 shares worth $366. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Altshuler Shaham first reported a position in FULC in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.13K in Q4 2025. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Altshuler Shaham held 100 shares of Fulcrum Therapeutics worth $366 as of Q2 2026.
  • Altshuler Shaham left its Fulcrum Therapeutics share count unchanged in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #464 holding.
  • Altshuler Shaham first reported a position in Fulcrum Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Altshuler Shaham's Fulcrum Therapeutics position peaked at $1.13K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.